Short Interest in MariMed Inc. (OTCMKTS:MRMD) Grows By 368.8%

MariMed Inc. (OTCMKTS:MRMD) was the target of a large increase in short interest during the month of March. As of March 31st, there was short interest totaling 65,750 shares, an increase of 368.8% from the March 15th total of 14,026 shares. Based on an average daily volume of 1,045,424 shares, the short-interest ratio is presently 0.1 days. Currently, 0.0% of the company’s stock are short sold.

Wall Street Analysts Forecast Growth

Separately, Zacks Research upgraded MariMed from a “strong sell” rating to a “hold” rating in a research note on Thursday, January 1st. Two investment analysts have rated the stock with a Hold rating, According to MarketBeat.com, MariMed presently has an average rating of “Hold”.

MariMed Stock Performance

MRMD stock opened at $0.07 on Monday. The company has a market cap of $27.80 million, a P/E ratio of -2.33 and a beta of 1.15. MariMed has a 1 year low of $0.06 and a 1 year high of $0.23. The company has a debt-to-equity ratio of 1.44, a current ratio of 1.00 and a quick ratio of 0.38. The stock’s fifty day moving average price is $0.08 and its 200-day moving average price is $0.10.

About MariMed

MariMed Inc is a multi‐state cannabis company focused on the development, ownership and operation of regulated facilities for the medical and adult‐use cannabis markets. Headquartered in New Bedford, Massachusetts, the company cultivates, processes and dispenses cannabis through an integrated business model that encompasses cultivation, formulation, manufacturing and retail operations. MariMed operates under its own licensed brands and through strategic partnerships to expand its presence across the United States.

The company’s product portfolio includes branded flower, pre‐rolls, vaporizer cartridges, tinctures, edibles and topicals designed to meet a range of consumer and patient needs.